Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract Tu091: Mechanism of beta1-adrenergic receptor signaling by IgG3 subclass of autoantibodies

View through CrossRef
Autoimmune response to self-antigens results in autoantibodies (AAbs), wherein AAbs against extra cellular loop (ECL) 2 of β1-adrenergic receptor (β1AR) is known to underlie dilated cardiomyopathy (DCM). Contrarily, recent studies show that patients with β1AR AAbs belonging to the IgG3 subclass have beneficial outcomes. However, the signaling mechanisms that underlie the beneficial outcomes are not well understood. We have previously shown that IgG3(+) β1AR AAbs facilitates uniquely biased β1AR signaling in response to β-blocker compared to non-IgG3(+) β1AR AAbs. Since IgG3(+) β1AR AAbs are associated with favorable patient outcomes, it is critical to determine the mechanistic basis of the unique beneficial signaling pathway that may have therapeutic potential. HEK 293 cells stably expressing human β1AR (HEK-β1AR) was generated and treated with β1AR AAbs. Minimal changes in phosphorylation of β1AR was observed following IgG3(+) β1AR AAbs, while significant phosphorylation of β1ARs was observed with non-IgG3(+) β1AR AAbs. To dissect the diverse signaling responses mediated by IgG3(+) and non-IgG(+) β1AR AAbs, HEK-β1AR cells were treated with IgG3(+) or non-IgG3(+) β1AR AAbs. β1ARs were immunoprecipitated and subjected to mass-spectrometry analysis to identify unique co-immunoprecipitating proteins that could complex with receptor in presence of IgG3(+) or non-IgG3(+) β1AR AAbs. One of the proteins that was differentially recruited to the β1AR complex was Insulin Receptor Substrate 4 (IRS4). Traditionally, IRS4 is a signaling hub downstream of insulin/insulin growth factor receptors mediating glucose uptake. The differential interaction of IRS4 with β1AR in the presence of IgG3(+) vs. non-IgG3(+) β1AR AAbs reflects that IRS4 could be a key signaling regulator of uniquely biased signal transduction pathway in the presence of IgG3(+) vs. non-IgG3(+) β1AR AAbs. Mechanisms underlying this unique IRS4 mediated signaling modulation will be discussed.
Title: Abstract Tu091: Mechanism of beta1-adrenergic receptor signaling by IgG3 subclass of autoantibodies
Description:
Autoimmune response to self-antigens results in autoantibodies (AAbs), wherein AAbs against extra cellular loop (ECL) 2 of β1-adrenergic receptor (β1AR) is known to underlie dilated cardiomyopathy (DCM).
Contrarily, recent studies show that patients with β1AR AAbs belonging to the IgG3 subclass have beneficial outcomes.
However, the signaling mechanisms that underlie the beneficial outcomes are not well understood.
We have previously shown that IgG3(+) β1AR AAbs facilitates uniquely biased β1AR signaling in response to β-blocker compared to non-IgG3(+) β1AR AAbs.
Since IgG3(+) β1AR AAbs are associated with favorable patient outcomes, it is critical to determine the mechanistic basis of the unique beneficial signaling pathway that may have therapeutic potential.
HEK 293 cells stably expressing human β1AR (HEK-β1AR) was generated and treated with β1AR AAbs.
Minimal changes in phosphorylation of β1AR was observed following IgG3(+) β1AR AAbs, while significant phosphorylation of β1ARs was observed with non-IgG3(+) β1AR AAbs.
To dissect the diverse signaling responses mediated by IgG3(+) and non-IgG(+) β1AR AAbs, HEK-β1AR cells were treated with IgG3(+) or non-IgG3(+) β1AR AAbs.
β1ARs were immunoprecipitated and subjected to mass-spectrometry analysis to identify unique co-immunoprecipitating proteins that could complex with receptor in presence of IgG3(+) or non-IgG3(+) β1AR AAbs.
One of the proteins that was differentially recruited to the β1AR complex was Insulin Receptor Substrate 4 (IRS4).
Traditionally, IRS4 is a signaling hub downstream of insulin/insulin growth factor receptors mediating glucose uptake.
The differential interaction of IRS4 with β1AR in the presence of IgG3(+) vs.
non-IgG3(+) β1AR AAbs reflects that IRS4 could be a key signaling regulator of uniquely biased signal transduction pathway in the presence of IgG3(+) vs.
non-IgG3(+) β1AR AAbs.
Mechanisms underlying this unique IRS4 mediated signaling modulation will be discussed.

Related Results

Abstract Wed055: Novel Metabolic Immuno-Allosteric Signaling by beta-1 Adrenergic Receptor Autoantibodies
Abstract Wed055: Novel Metabolic Immuno-Allosteric Signaling by beta-1 Adrenergic Receptor Autoantibodies
Autoimmune responses targeting β1-adrenergic receptor (β1AR) leading to the production of autoantibodies (AAbs) are implicated in the pathogenesis of dilated cardiomyopathy (DCM). ...
Abstract Fri163: Unraveling the complexity of β1AR autoantibodies
Abstract Fri163: Unraveling the complexity of β1AR autoantibodies
Autoantibodies (AAbs) that activate beta1-adrenoreceptor (β1AR) are linked to heart failure (HF) progression. Circulating β1AR-AAbs, especially those targeting the second extracell...
Adrenergic and Cholinergic Regulation of in vitro Melatonin Release during Ontogeny in the Pineal Gland of Long Evans Rats
Adrenergic and Cholinergic Regulation of in vitro Melatonin Release during Ontogeny in the Pineal Gland of Long Evans Rats
Melatonin, produced by the pineal gland, plays an important role in a great variety of neuroendocrine functions. The rhythmic release of melatonin by the mammalian pineal gland is ...
Marginal Zone B Cells Transport IgG3-Immune Complexes to Splenic Follicles
Marginal Zone B Cells Transport IgG3-Immune Complexes to Splenic Follicles
Abstract Ag administered together with specific IgG3 induces a higher Ab response than Ag administered alone, an effect requiring the presence of complement receptor...
Evaluation of multiple autoantibodies to tumor-associated antigens as potential diagnostic markers for pancreatic cancer
Evaluation of multiple autoantibodies to tumor-associated antigens as potential diagnostic markers for pancreatic cancer
The aim of the study is to evaluate the clinical significance of autoantibodies to GNA11, MSLN, GNAS, CEBPA, MDM2, p16, Sui1, Calnuc, PTEN in Pancreatic Cancer (PC). A total of 33 ...
FcγRIIB regulates (auto)antibody responses by limiting marginal zone B cell activation
FcγRIIB regulates (auto)antibody responses by limiting marginal zone B cell activation
AbstractFcγRIIB is an inhibitory receptor expressed throughout B cell development. Diminished expression or function is associated with lupus in mice and humans, in particular thro...
IgG Subclasses Abnormal in Immune-Related Pancytopenia
IgG Subclasses Abnormal in Immune-Related Pancytopenia
Abstract In recent years, we found some patients with idiopathic cytopenia of undetermined significance (ICUS)responded well to corticosteroid and/or high-dose intra...

Back to Top